These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 21515053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE, Geis U, Grahner B, Lanzner W, Eger K.
    J Med Chem; 1996 Jun 21; 39(13):2482-91. PubMed ID: 8691445
    [Abstract] [Full Text] [Related]

  • 4. Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor.
    Burch JD, Farand J, Colucci J, Sturino C, Ducharme Y, Friesen RW, Lévesque JF, Gagné S, Wrona M, Therien AG, Mathieu MC, Denis D, Vigneault E, Xu D, Clark P, Rowland S, Han Y.
    Bioorg Med Chem Lett; 2011 Feb 01; 21(3):1041-6. PubMed ID: 21215624
    [Abstract] [Full Text] [Related]

  • 5. Refinement of the benzodiazepine receptor site topology by structure-activity relationships of new N-(heteroarylmethyl)indol-3-ylglyoxylamides.
    Primofiore G, Da Settimo F, Marini AM, Taliani S, La Motta C, Simorini F, Novellino E, Greco G, Cosimelli B, Ehlardo M, Sala A, Besnard F, Montali M, Martini C.
    J Med Chem; 2006 Apr 20; 49(8):2489-95. PubMed ID: 16610792
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists.
    Lattmann E, Singh H, Boonprakob Y, Lattmann P, Sattayasai J.
    J Pharm Pharmacol; 2006 Mar 20; 58(3):393-401. PubMed ID: 16536908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G, Butini S, Trotta F, Fattorusso C, Catalanotti B, Aiello F, Gemma S, Nacci V, Novellino E, Stark JA, Cagnotto A, Fumagalli E, Carnovali F, Cervo L, Mennini T.
    J Med Chem; 2003 Aug 28; 46(18):3822-39. PubMed ID: 12930145
    [Abstract] [Full Text] [Related]

  • 9. Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptors.
    Peglion JL, Poitevin C, Mannoury La Cour C, Dupuis D, Millan MJ.
    Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2133-8. PubMed ID: 19324548
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
    Yang MG, Xiao Z, Shi Q, Cherney RJ, Tebben AJ, De Lucca GV, Santella JB, Mo R, Cvijic ME, Zhao Q, Barrish JC, Carter PH.
    Bioorg Med Chem Lett; 2012 Feb 01; 22(3):1384-7. PubMed ID: 22225639
    [Abstract] [Full Text] [Related]

  • 11. The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.
    Cowley PM, Baker J, Barn DR, Buchanan KI, Carlyle I, Clark JK, Clarkson TR, Deehan M, Edwards D, Goodwin RR, Jaap D, Kiyoi Y, Mort C, Palin R, Prosser A, Walker G, Ward N, Wishart G, Young T.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):497-501. PubMed ID: 21075628
    [Abstract] [Full Text] [Related]

  • 12. Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
    Zhang X, Li X, Allan GF, Musto A, Lundeen SG, Sui Z.
    Bioorg Med Chem Lett; 2006 Jun 15; 16(12):3233-7. PubMed ID: 16603353
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F, Guiblin AR, Jelley RA, Matassa VG, Reeve AJ, Hunt PA, Beer MS, Heald A, Stanton JA, Sohal B, Watt AP, Street LJ.
    J Med Chem; 1999 Feb 25; 42(4):677-90. PubMed ID: 10052975
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design and synthesis of novel 3-substituted-indole derivatives as selective H3 receptor antagonists and potent free radical scavengers.
    Tang L, Zhao L, Hong L, Yang F, Sheng R, Chen J, Shi Y, Zhou N, Hu Y.
    Bioorg Med Chem; 2013 Oct 01; 21(19):5936-44. PubMed ID: 23978359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.
    Mach UR, Hackling AE, Perachon S, Ferry S, Wermuth CG, Schwartz JC, Sokoloff P, Stark H.
    Chembiochem; 2004 Apr 02; 5(4):508-18. PubMed ID: 15185375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.